Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
3.670
+0.020 (0.55%)
At close: May 30, 2025, 4:00 PM
3.640
-0.030 (-0.82%)
After-hours: May 30, 2025, 7:53 PM EDT
Bionano Genomics Revenue
Bionano Genomics had revenue of $6.46M in the quarter ending March 31, 2025, a decrease of -26.37%. This brings the company's revenue in the last twelve months to $28.46M, down -24.04% year-over-year. In the year 2024, Bionano Genomics had annual revenue of $30.78M, down -14.79%.
Revenue (ttm)
$28.46M
Revenue Growth
-24.04%
P/S Ratio
0.22
Revenue / Employee
$284,640
Employees
100
Market Cap
11.04M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
BNGO News
- 11 days ago - Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders - GlobeNewsWire
- 16 days ago - Bionano Genomics, Inc. (BNGO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress - GlobeNewsWire
- 17 days ago - Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies - GlobeNewsWire
- 23 days ago - Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025 - GlobeNewsWire
- 4 weeks ago - International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers - GlobeNewsWire
- 5 weeks ago - Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease - GlobeNewsWire
- 7 weeks ago - Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM - GlobeNewsWire